The drug of abuse testing market is projected to grow from USD 1.65 billion in 2023 to USD 2.69 billion by 2033, at a CAGR of ...
Three stocks that have not only been around for a century but have also been paying dividends for that long are Coca-Cola ...
The biomarker discovery segment held the second-largest market share. Based on end users, the genomics product market is segmented into hospitals, clinics and diagnostic laboratories, academic & ...
As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
The global companion diagnostics for oncology market size was US$ 2.9 billion in 2021. The global companion diagnostics for oncology market is forecast to grow to US$ 9.1 billion by 2030 by ...
The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...
With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.
Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.
The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...
Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand ...